Medtronic
TriMed Staff | October 08, 2008 | Cardiovascular Business | Patient Care
Medtronic (Booth 826) is featuring clinical research updates from its international RESOLUTE trials, designed to assess the safety and efficacy of its Endeavor Resolute drug-eluting stent (DES) system, which is an investigational device in the U.S., but commercially available in Europe.

Clinical research teams led by interventional cardiologists James Carr, MD, at East Texas Medical Center in the United States and Prof. Dr. Franz-Josef Neumann at the Heart Center of Bad Krozingen in Germany are enrolling patients in RESOLUTE US (R-US) and RESOLUTE International (R-Int), respectively. 

The Endeavor Resolute DES uses the proprietary BioLinx polymer, which was designed to meet the same biocompatibility requirements as the phosphorylcholine (PC) polymer used in Medtronic's Endeavor stent. Compared to the PC polymer, the BioLinx polymer is designed to extend the duration of drug exposure in the vessel.

TriMed Staff

Related Content

Cardiologist moves to Mississippi to fight back against PAD and limit amputations
On-pump vs. off-pump CABG: No difference in long-term mortality, meta-analysis confirms
Peripheral artery disease is out of control in many rural, low income communities
The many benefits of using low-cost CT coronary calcium scoring to screen patients
Early feasibility study for implantable heart failure monitor moves forward 
Using 'magic' to calm pediatric patients during imaging exams

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup